No 1 Date of announcement 2026/02/23 Time of announcement 16:47:47 Subject Announcement for the expected date of Board of Directors Meeting for the 2025 financial statements is 2026/3/3 Date of events 2026/02/23 To which item it meets paragraph 31 Date of a notice of the board of directors meeting is issued:2026/02/23 Expected date of the...Read More
S&P Global, the world’s leading authority of ESG ratings and research, recently released “The S&P Global Sustainability Yearbook 2026.” Microbio Group delivered an outstanding performance: its subsidiary Oneness Biotech Co., Ltd. (4743) has been selected for the fourth consecutive year, while Diamond BioFund Inc. (6901) and Microbio Co., Ltd. (4128) made their debut on the...Read More
No 1 Date of announcement 2026/02/06 Time of announcement 15:19:04 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2026/02/06 To which item it meets paragraph 51 Date of occurrence of the event:2026/02/06...Read More
No 2 Date of announcement 2026/01/08 Time of announcement 17:00:27 Subject Announcement for the Company’s commitments made when applying for listing of stock and its subsequent implementation. Date of events 2026/01/08 To which item it meets paragraph 51 1. Date of occurrence of the event: 2026/01/08 2. Company name:Diamond Biofund Inc. 3. Relationship to the Company...Read More
No 1 Date of announcement 2026/01/08 Time of announcement 17:00:08 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2026/01/08 To which item it meets paragraph 51 Date of occurrence of the event:2026/01/08...Read More
No 1 Date of announcement 2025/12/22 Time of announcement 18:08:51 Subject Announcement of Board of Directors’ resolution on the appointment of the Company’s Acting spokesperson and Financial officer. Date of events 2025/12/22 To which item it meets paragraph 8 Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel (CEO, COO, CMO, CSO, etc.),...Read More
No 1 Date of announcement 2025/12/15 Time of announcement 18:06:16 Subject The Company announces the information about the investor conference of Q4, 2025. Date of events 2025/12/23 To which item it meets paragraph 12 Date of institutional investor conference:2025/12/23 Time of institutional investor conference:15:00 (GMT+8) Location of institutional investor conference: Online investor conference Outline of...Read More
發布日期：2025-12-09 原始連結：https://pharmaboardroom.com/interviews/yenchen-huang-head-of-investment-vp-diamond-biofund-taiwan/ PHARMA BOARDROOM｜2025.12.09 We describe ourselves as “entrepreneurs behind entrepreneurs” – not merely passive capital providers but active partners throughout the journey. Yenchen Huang – Head of Investment & VP, Diamond Biofund, Taiwan How does dual scientific and investment expertise shape investment decisions at Diamond Biofund? Diamond Biofund’s investment...Read More
December 8, 2025 PRNewswire NES ZIONA, Israel, Dec. 8, 2025 /PRNewswire/ — EyeYon Medical Ltd., a global leader in ophthalmic innovation, today announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a U.S. clinical study of EndoArt®, the world’s first synthetic endothelial layer for the treatment of chronic corneal edema. EndoArt®...Read More
No 1 Date of announcement 2025/12/05 Time of announcement 17:14:17 Subject Announcement for the changes in the numbers of shares and their fair value held in the Company’s portfolio as well as the Company’s BVPS and cash balance. Date of events 2025/12/05 To which item it meets paragraph 51 Date of occurrence of the event:2025/12/05...Read More
